George Putnam
The Turnaround Letter
Geoffrey Seiler
Bullmarket.com
Chuck Carlson
The DRIP Investor
Nicholas Vardy
Bull Market Alert

Revlon (REV): A beauty buy


Bookmark and Share

 "Revlon (NYSE: REV) promises a better look for both consumers and investors," says Ian Wyatt. In his The SmallCap Investor, he says, "The company is firing on all cylinders." 

"Revlon, a $770 million market cap consumer goods company has seen its shares surged 220% since October 1. 

"The New York City based company makes, markets, and sells a range of women’s cosmetics, hair-care, beauty-care, and skin-care products.

Advertisement
Banner

"We’re not talking about a high margin business here - Revlon has a paltry 3.7% profit margin over the last twelve months. 

"But the company is firing on all cylinders – it generated free cash flow for the first time since its IPO in 1996 and has grabbed 22.3% market share in lip makeup – good enough to put it back at number one.

"Revlon has grown 2009 earnings at a clip of 304% over 2008, reporting EPS of $0.45 in the third quarter.  Trailing 12-month earnings are $0.92 per share – not bad for a company that analysts had expected to lose $0.47 per share in the last three quarters.

"Investor’s can by shares of Revlon at 16.5 times trailing 12-month earnings – a significant discount to large-cap competitor Estee Lauder, which has a trailing earnings multiple of 30.

"Revlon is getting its debt load in order – and the results are paying off, literally. On November 9 the company received lender consent to issue $330 million in senior-secured debt, due in 2015. This allowed the company to refinance its high-interest debt that had been due April 2011.

"The stock surged 38% after these financing moves. Many other companies have been forced to dilute shareholder value with equity offerings, only to be rewarded with crushed share prices.

"Clearly, the fact that Revlon was able to refinance and sell debt in an economy where credit has been tight –- especially for notes that Moody’s rates B3, or ‘junk’ – is a testament to the company’s strength.

"Even in an environment of high unemployment, people want to take care of themselves. And perhaps you can help take care of your investment portfolio with health and beauty stocks like Revlon."


News Flash

Goldcorp: 'My favorite major'
by Curtis Hesler, editor Professional Timing Service

The secular bull in gold and the commodity sector is not over. However, it is not at the ground floor any longer either; as such, stock selection must be more carefully considered.


Read more...

 

Money manager's small cap buys
by Jim Oberweis Jr., editor The Oberweis Report

Small-cap growth stock valuations are cheap, and like most things in life, economies are cyclical, even if this is a long and painful one. For the rare, brave contrarian with a reasonably long time horizon, that spells opportunity.


Read more...


   

Opportunities in homebuilding?
by Bernie Schaeffer, editor Schaeffer's Investment Research

Based on our "expectational analysis" strategy -- which  combines fundamental, sentiment and technical metrics -- I initiated long positions in two homebuilding stocks: Lennar Corporation (LEN) and Toll Brothers (TOL).


Read more...

 

Cliffs Natural: A DRIP favorite
by Vita Nelson, editor MoneyPaper

Our latest featured dividend reinvestment stock is Cliffs Natural Resources (CLF). Founded in 1847, the former Cleveland-Cliffs is the largest producer of iron ore pellets in North America.


Read more...

 

S&P's trio of info tech ETFS
by Dylan Cathers, S&P Capital IQ Equity Analyst, S&P The Outlook

Information technology is one of four sectors that S&P Capital IQ’s Sector Strategy Group currently recommends investors overweight in their portfolios.


Read more...

 

Crescent Point: Bakken bet
by Brian Hicks, editor Wealth Advisory

Master Limited Partnerships (MLPs) are unique investments that combine the tax benefits of a limited partnership (LP) with the liquidity of common stock.


Read more...

 

Natural gas: A bottom?
by Jason Cimpl, editor Daily Profit

Natural gas has collapsed for the past four years and has been on a gradual decline for almost a decade. Prices topped near $16 in 2005 and then declined to $2. So did natural gas just bottom?


Read more...

 

FBR Focus bests 99% of peers
by Walter Frank, editor MoneyLetter

Funds that invest in a relatively few stocks or sectors are less diversified than broadly invested funds and their volatility can be much higher. But the team at FBR Focus (FBRVX) seems to be getting it right.


Read more...

 

Celgene: Catalysts ahead
by John McCamant, editor Medical Technology Stock Letter

Celgene (CELG) recently kicked off the 2012 JP Morgan Healthcare conference by pre-announcing 4Q11 results and providing 2012 guidance.


Read more...

 

Water, water
by Richard Band, editor Profitable Investing

In the current environment, investors should focus any new stock purchases on companies with recession-resistant franchises and generous dividends -- such as water utilities.


Read more...